1792-362x

Forum of Clinical Oncology

De Gruyter Poland Sp. z o.o.

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 32 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact32 DOIs
2

Deposit reference lists for 20 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

High impact20 DOIs
3

Add abstracts to 2 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact2 DOIs

DOIs for this ISSN

Showing the top 5 of 32 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Single Fraction versus Multiple Fraction Radiotherapy for tr… (10.1515/fco-2015-0007)
References ORCID
57.31 13
2 The Efficacy of Thyrotropin Suppression Therapy in Treatment… (10.1515/fco-2015-0010)
References ORCID
52.07 10
3 Healthcare access for cancer patients in the era of economic… (10.1515/fco-2015-0020)
References ORCID
42.25 6
4 The Various Shapes of Innovation (10.1515/fco-2015-0019)
References ORCID
30.10 3
5 Trismus and reduced quality of life in patients with oral sq… (10.1515/fco-2015-0023)
ORCID
23.86 8
6 Cardiotoxicity of the adjuvant trastuzumab in a Saudi popula… (10.1515/fco-2016-0007)
ORCID
21.13 6
7 Localised gastrointestinal diffuse large B cell lymphomas; D… (10.1515/fco-2015-0003)
References ORCID
15.05 1
8 Efficacy and Toxicity of Maintenance Pemetrexed Following In… (10.1515/fco-2015-0008)
References ORCID
15.05 1
9 Clinicopathologic Profile and Outcome of Extranodal Diffuse… (10.1515/fco-2015-0013)
References ORCID
15.05 1
10 Metastatic Renal Cell Carcinoma: Sunitinib as First-Line Tre… (10.1515/fco-2015-0017)
References ORCID
15.05 1
11 Reorganisation of Oncologic Care in Greece: A Proposal (10.1515/fco-2015-0018)
References ORCID
15.05 1
12 The expanding new era of cancer immunotherapy (10.1515/fco-2016-0003)
Abstract ORCID
15.05 1
13 Developing an algorithm for the management of Renal Cell Car… (10.1515/fco-2015-0025)
ORCID
7.53 1
14 Targeting Bruton Tyrosine Kinase: A novel strategy in the tr… (10.1515/fco-2015-0026)
ORCID
7.53 1
15 Overview and management of toxicities of immune checkpoint-b… (10.1515/fco-2016-0004)
ORCID
7.53 1
16 Metabolic syndrome and Cancer: Do they share common molecula… (10.1515/fco-2016-0006)
ORCID
7.53 1
17 Gastrointestinal obstruction in palliative care: a review (10.1515/fco-2015-0001)
References ORCID
0.00 0
18 Langerhans cell histiocytosis following treatment for testic… (10.1515/fco-2015-0002)
References ORCID
0.00 0
19 Long-term Survival of Patients with Breast Cancer and Brain… (10.1515/fco-2015-0004)
References ORCID
0.00 0
20 Prognostic significance of plasma osteopontin level in breas… (10.1515/fco-2015-0005)
References ORCID
0.00 0
21 Patient-reported outcomes for immediate identification of de… (10.1515/fco-2015-0006)
References ORCID
0.00 0
22 Frequency of EGFR Mutation and EML4-ALK fusion gene in Arab… (10.1515/fco-2015-0009)
References ORCID
0.00 0
23 Editorial (10.1515/fco-2015-0011)
Abstract References ORCID
0.00 0
24 The role of Pazopanib in Soft Tissue Sarcoma: A comprehensiv… (10.1515/fco-2015-0012)
References ORCID
0.00 0
25 OLAPARIB: A promising PARP Inhibitor for the treatment of ov… (10.1515/fco-2015-0014)
References ORCID
0.00 0
26 Evaluation of the prognostic benefit of identifying the prob… (10.1515/fco-2015-0015)
References ORCID
0.00 0
27 Living with breast cancer: Patients’ journey within the Gree… (10.1515/fco-2015-0016)
References ORCID
0.00 0
28 Targeting the PD-1/PD-L1 axis in the treatment of lung cance… (10.1515/fco-2015-0021)
ORCID
0.00 0
29 BRCA1/2 associated cancer susceptibility: a clinical overvie… (10.1515/fco-2015-0022)
ORCID
0.00 0
30 Is postoperative radioactive iodine associated with a surviv… (10.1515/fco-2015-0027)
ORCID
0.00 0
31 Reinstating endogenous antitumor immunity: The concept of th… (10.1515/fco-2016-0005)
ORCID
0.00 0
32 The Role of Genetics in Sporadic GEP-NETs: A Comprehensive R… (10.1515/fco-2017-0001)
ORCID
0.00 0